ResearchSafe

Switching from KLOW to GLOW after 8 weeks, worth dropping KPV?

Posted by nina489 in Protocols & Stacks - 7 points, 6 comments.

I am basically finishing up an 8-week KLOW run (the full four-compound version with KPV included) and I am thinking about transitioning to GLOW for another 6-8 weeks as a sort of maintenance phase. The idea would be to drop KPV since my inflammation feels more under control now, no?

My KLOW dosing was the standard one. GHK-Cu 200mcg and BPC-157 500mcg daily, KPV 500mcg daily, TB-500 2.5mg twice a week. For me the recovery effect was noticeable (could be partly placebo, I accept that) but the injection site irritation from GHK-Cu was annoying the whole time.

So my question is whether it makes sense to go straight into GLOW or if I should take a full break first. I have seen people say 4 weeks off between stacks but I am not sure if that applies when the overlapping compounds are the same ones, right?

Also, for GLOW the listed dose keeps GHK-Cu daily but drops TB-500 to 2-3x per week. That is basically what I was already doing. Would there be any point in running it at all if the only real change is removing KPV? Seems like a very small adjustment.

Any feedback on the transition timing or whether this is just redundant would be helpful.

Comments

  • tracker_jade: I’ve tried something similar – after eight weeks on KLOW I dropped KPV and moved straight into GLOW for another six weeks without a break. For me the recovery felt about the same, though I did notice a bit less irritation at the GHK‑Cu sites, which could just be because I was using a slightly lower volume that week. Anecdotally, the only real change was losing KPV, and I didn’t see any extra benefit from keeping it in the stack. If your inflammation is already under control, skipping KPV might
  • grinder_busy116: The two-week washout idea is probably the smarter move imo. Going straight from one stack into another without a break makes it hard to tell what's actually doing what? If inflammation is already dialed in, you'd have a cleaner baseline to compare against. Did you run bloodwork at all during the transition or just going by feel?
  • curious_scientist: The two-week washout idea is smart imo. I skipped a break once going from one stack straight into another and honestly couldn't tell what was doing what anymore. Resetting baseline kinda helps you actually notice if dropping KPV changes anything. Did you track anything specific during those six weeks on GLOW or just going by feel?
  • nina489: I think I will do the two weeks off. I do not want to be confused like you were when you skipped your break. Basically I am just going by feel for now, no? I have not tracked anything with a log or a scale. I just notice the inflammation is lower. Maybe I should start a simple journal for the GLOW phase so I can actually see if dropping KPV makes a difference.
  • nina489: Only going by feel, no bloodwork yet. I like the two-week washout idea to reset baseline before GLOW, especially since GHK-Cu irritation was constant. Might try that and see if any leftover KPV effect lingers.
  • nina489: The lower volume thing for GHK-Cu irritation is interesting, I did not think of that as a factor. Were you still doing daily GHK-Cu injections during GLOW or did you space them out more? That irritation was my main annoyance the whole 8 weeks so if the volume reduction helped you, maybe I should pay more attention to that. The two-week washout idea sounds reasonable to me. I was worried that a full 4 weeks off would slow down the momentum I have with recovery, no? But two weeks feels like a goo

Community discussion - research and educational context only. Not medical advice.